JMP Group LLC announced that Reni Benjamin, Ph.D. has joined JMP Securities as a managing director and equity research analyst covering biotechnology. Based in the firm’s New York office, Dr. Benjamin will focus on the oncology sector. Dr. Benjamin joins JMP Securities from Raymond James, where he was a managing director and senior research analyst. Dr. Benjamin was previously a managing director at H.C. Wainwright & Co. and Rodman & Renshaw, after starting his career in biotechnology research at Needham & Company.